Characteristics | Median [IQR] | Range (min - max) |
---|---|---|
Year of publication (year) | 2010 [2007–2013] | 1997 - 2014 |
Sample size (N)a | 129 [56–359] | 1 - 9105 |
Sample mean age (year)a | 58 [52–64] | 11 - 77 |
Sample mean percentage of female (%) | 61 [41–100] | 0 - 100 |
 | Number of articles (k) | Percentage (%) |
Country where participants came from | Â | Â |
Canada | 110 | 51.9 |
USA | 65 | 30.7 |
Australia | 11 | 5.2 |
UK | 9 | 4.2 |
Other countriesb,c | 17 | 8.0 |
Cancer site | Â | Â |
Breast | 61 | 28.8 |
Prostate | 19 | 9.0 |
Colorectal | 16 | 7.5 |
Lung | 12 | 5.7 |
Hematological (leukemia, myeloma) | 10 | 4.7 |
Hodgkin/non-Hodgkin lymphoma | 8 | 3.8 |
Endometrial | 7 | 3.3 |
Brain/glioma | 7 | 3.3 |
Head/neck/oral cavity | 5 | 2.4 |
Ovarian | 5 | 2.4 |
Kidney | 5 | 2.4 |
Bladder | 3 | 1.4 |
Survivors from different types of cancer | 54 | 25.5 |